Ecromeximab
Ecromeximab (KM 871; KW 2871) is a mouse-derived IgG-κ chimeric antibody targeting ganglioside GD3. Ecromeximab is expressed by YB2/0 rat hybridoma cells[1].
Product Specifications
CAS Number
292819-64-8
Product Name Alternative
KM 871; KW 2871
UNSPSC
12352203
Target
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/ecromeximab.html
Purity
99.70
Solubility
10 mM in DMSO
Smiles
[Ecromeximab]
Molecular Weight
(145.26 kDa)
References & Citations
[1]Ecromeximab. IMGT.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog